Overview Financials News + Filings Key Docs Charts Ownership
|
|
Mindray Medical International LTD (MR)
|
Add to portfolio |
|
|
|
| Price: |
$22.48
| | Metrics |
| OS: |
117.1
|
M
| |
|
|
| Market cap: |
$2.63
|
B
| |
|
|
|
Net cash:
|
$886
|
M
| |
$7.57
|
per share
|
|
EV:
|
$1.75
|
B
| | | |
| | | | | |
| TTM Valuation | | | |
|
EBITDA
|
|
| |
|
|
|
EBIT
|
|
| |
|
|
| EPS |
| |
|
|
|
|
| |
|
|
|
Recent News + Filings (All items)
| Date Filed | Type | Description |
| 10/20/2020 |
GN
| Rigrodsky & Long, P.A. Files Class Action Suit Against Montage Resources Corporation |
| 10/15/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Montage Resources Corporation (NYSE: MR), MyoKardia, Inc. (NASDAQ: MYOK), Standard AVB Financial Corp....
|
| 09/02/2020 |
GN
| SHAREHOLDER ALERT: Rigrodsky & Long, P.A. Reminds Investors of Investigations of NTN, MVC, MR, and GLIBA Mergers |
| 08/14/2020 |
GN
| Lifshitz Law Firm, P.C. Announces Investigation of Cellular Biomedicine Group, Inc. (NASDAQ: CBMG), Montage Resources Corporation (NYSE: MR), Noble Energ...
|
| 03/15/2016 |
15-12B
| Form 15-12B - Securities registration termination [Section 12(b)] |
| 03/07/2016 |
SC 13G/A
| Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] |
| 03/04/2016 |
25-NSE
| Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securities |
|
Revenue Mix by Segment
|
Financial Summary (All financials)
| In millions, except per share items | Dec-31-14 | Dec-31-13 | Dec-31-12 | Dec-31-11 | Dec-31-10 | Dec-31-09 |
| Revenues | 1,322.8 | 1,214.0 | 1,060.1 | 880.7 | 704.3 | 634.2 |
| Revenue growth | 9.0% | 14.5% | 20.4% | 25.1% | 11.1% | |
| Cost of goods sold | 584.3 | 527.4 | 459.4 | 394.3 | 303.3 | 280.3 |
| Gross profit | 738.5 | 686.6 | 600.7 | 486.4 | 401.0 | 353.9 |
| Gross margin | 55.8% | 56.6% | 56.7% | 55.2% | 56.9% | 55.8% |
| Sales and marketing | | 220.6 | | 167.0 | 123.0 | 106.1 |
| Research and development | | 127.5 | | 82.0 | 60.3 | 58.4 |
| General and administrative | 137.0 | 128.3 | 116.2 | 70.3 | 61.2 | 47.5 |
| EBITA | 616.0 | 230.0 | 493.4 | 176.6 | 163.0 | 148.8 |
| EBITA margin | 46.6% | 18.9% | 46.5% | 20.1% | 23.1% | 23.5% |
| Amortization of intangibles | 21.3 | 19.7 | 13.1 | 9.6 | 7.5 | 8.1 |
| EBIT | 594.7 | 210.2 | 480.2 | 167.0 | 155.6 | 140.6 |
| EBIT margin | 45.0% | 17.3% | 45.3% | 19.0% | 22.1% | 22.2% |
| Pre-tax income | 234.5 | 244.8 | 219.7 | 189.6 | 173.1 | 168.0 |
| Income taxes | 35.5 | 14.3 | 37.4 | 22.6 | 17.6 | 28.8 |
| Tax rate | 15.1% | 5.8% | 17.0% | 11.9% | 10.2% | 17.1% |
| Net income | 193.3 | 224.8 | 178.1 | 166.6 | 155.5 | 139.2 |
| Net margin | 14.6% | 18.5% | 16.8% | 18.9% | 22.1% | 21.9% |
| |
| Diluted EPS | $1.63 | $1.87 | $1.49 | $1.41 | $1.32 | $1.23 |
| Shares outstanding (diluted) | 118.4 | 120.1 | 119.8 | 118.4 | 117.6 | 113.0 |
| |
| EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |
|
|